CAPTRUST Financial Advisors’s ProShares Ultra Health Care RXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-400
| Closed | -$17K | – | 3660 |
|
|
2022
Q2 | $17K | Hold |
400
| – | – | ﹤0.01% | 3459 |
|
|
2022
Q1 | $20K | Hold |
400
| – | – | ﹤0.01% | 3392 |
|
|
2021
Q4 | $22K | Hold |
400
| – | – | ﹤0.01% | 3229 |
|
|
2021
Q3 | $19K | Hold |
400
| – | – | ﹤0.01% | 3204 |
|
|
2021
Q2 | $19K | Hold |
400
| – | – | ﹤0.01% | 3147 |
|
|
2021
Q1 | $16K | Hold |
400
| – | – | ﹤0.01% | 3153 |
|
|
2020
Q4 | $15K | Hold |
400
| – | – | ﹤0.01% | 2400 |
|
|
2020
Q3 | $13K | Hold |
400
| – | – | ﹤0.01% | 2180 |
|
|
2020
Q2 | $12K | Buy |
+400
| New | +$11.3K | ﹤0.01% | 2123 |
|
|
2019
Q4 | – | Sell |
-400
| Closed | -$10K | – | 1636 |
|
|
2019
Q3 | $10K | Hold |
400
| – | – | ﹤0.01% | 1506 |
|
|
2019
Q2 | $11K | Hold |
400
| – | – | ﹤0.01% | 1481 |
|
|
2019
Q1 | $10K | Hold |
400
| – | – | ﹤0.01% | 1389 |
|
|
2018
Q4 | $9K | Hold |
400
| – | – | ﹤0.01% | 1248 |
|
|
2018
Q3 | $12K | Hold |
400
| – | – | ﹤0.01% | 1180 |
|
|
2018
Q2 | $9K | Hold |
400
| – | – | ﹤0.01% | 1206 |
|
|
2018
Q1 | $8K | Hold |
400
| – | – | ﹤0.01% | 1086 |
|
|
2017
Q4 | $9K | Hold |
400
| – | – | ﹤0.01% | 1022 |
|
|
2017
Q3 | $9K | Hold |
400
| – | – | ﹤0.01% | 443 |
|
|
2017
Q2 | $8K | Buy |
+400
| New | +$7.37K | ﹤0.01% | 229 |
|
|
2017
Q1 | – | Sell |
-400
| Closed | -$6K | – | 165 |
|
|
2016
Q4 | $6K | Buy |
+400
| New | +$6.06K | ﹤0.01% | 165 |
|
|
2016
Q2 | – | Sell |
-1,936
| Closed | -$28K | – | 164 |
|
|
2016
Q1 | $28K | Hold |
1,936
| – | – | ﹤0.01% | 132 |
|
|
2015
Q4 | $32K | Hold |
1,936
| – | – | ﹤0.01% | 135 |
|
|
2015
Q3 | $28K | Hold |
1,936
| – | – | ﹤0.01% | 121 |
|
|
2015
Q2 | $36K | Hold |
1,936
| – | – | 0.01% | 103 |
|
|
2015
Q1 | $34.2K | Hold |
1,936
| – | – | 0.01% | 111 |
|
|
2014
Q4 | $30K | Buy |
+1,936
| New | +$28.5K | 0.01% | 105 |
|
|
2014
Q3 | – | Sell |
-1,936
| Closed | -$24K | – | 120 |
|
|
2014
Q2 | $24K | Hold |
1,936
| – | – | 0.01% | 107 |
|
|
2014
Q1 | $22K | Hold |
1,936
| – | – | ﹤0.01% | 123 |
|
|
2013
Q4 | $20K | Hold |
1,936
| – | – | ﹤0.01% | 125 |
|
|
2013
Q3 | $17K | Hold |
1,936
| – | – | ﹤0.01% | 118 |
|
|
2013
Q2 | $15K | Buy |
+1,936
| New | +$14.7K | ﹤0.01% | 128 |
|
Other funds holding RXL
PFA
TRCT
TFA
OMC
CAPTRUST Financial Advisors's RXL Position: Q3 2022 in Review
CAPTRUST Financial Advisors sold out of ProShares Ultra Health Care (RXL) in Q3 2022, closing a stake of 400 shares — an estimated $17K sold.
CAPTRUST Financial Advisors first reported a position in RXL in Q2 2013 and held it in 31 quarters. The position peaked at $36K in Q2 2015. 20 funds tracked by Wall St. Rank hold RXL as of Q3 2022.
- CAPTRUST Financial Advisors reported no remaining ProShares Ultra Health Care position as of Q3 2022 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 400 ProShares Ultra Health Care shares in Q3 2022, an estimated $17K.
- CAPTRUST Financial Advisors first reported a position in ProShares Ultra Health Care in Q2 2013 and held it in 31 quarters.
- CAPTRUST Financial Advisors's ProShares Ultra Health Care position peaked at $36K in Q2 2015.
- 20 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2022.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.